Our study also demonstrates that subtypes of glioma have a high IDH mutation frequency and that these are known to improve survival and exhibit similar traits; however, different effects can be derived from the same gene, and this would result in survival differences in different subtypes such as ODs and astrocytomas. The gene discussed is IDH2; the disease is glioma.